0001209191-17-053312.txt : 20170919 0001209191-17-053312.hdr.sgml : 20170919 20170919165800 ACCESSION NUMBER: 0001209191-17-053312 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170918 FILED AS OF DATE: 20170919 DATE AS OF CHANGE: 20170919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdollahian Neil CENTRAL INDEX KEY: 0001678223 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36912 FILM NUMBER: 171092509 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cidara Therapeutics, Inc. CENTRAL INDEX KEY: 0001610618 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461537286 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-752-6170 MAIL ADDRESS: STREET 1: 6310 NANCY RIDGE DRIVE STREET 2: SUITE 101 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: K2 THERAPEUTICS, INC. DATE OF NAME CHANGE: 20140611 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-18 0 0001610618 Cidara Therapeutics, Inc. CDTX 0001678223 Abdollahian Neil 6310 NANCY RIDGE DR SUITE 101 SAN DIEGO CA 92121 0 1 0 0 Chief Business Officer Common Stock 2017-09-18 4 A 0 15000 0.00 A 20421 D Restricted Stock Unit 2017-09-18 4 M 0 25000 0.00 A Common Stock 25000 25000 D 1/3rd of the total number of shares subject to the restricted stock unit shall vest on each December 31 of 2018, 2019 and 2020. Includes 1,421 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 19, 2017. Restricted stock units convert into common stock on a one-for-one basis. A portion of the shares vest upon the achievement of various clinical and corporate milestones. /s/ Marc Wilson, Attorney-in-fact 2017-09-19